AML ELN 2022 Favorable/Adverse Risk

Classify AML risk per European Leukemia Net 2022 criteria into favorable, intermediate, or adverse categories based on cytogenetics and molecular mutations to guide induction and consolidation decisions.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Classify AML risk per European Leukemia Net 2022 criteria into favorable, intermediate, or adverse categories based on cytogenetics and molecular mutations to guide induction and consolidation decisions

Each component has a specific meaning:

  • Cytogenetics — The cytogenetics recorded for the scenario being assessed.
  • Molecular mutations — The molecular mutations recorded for the scenario being assessed.

Note: Interpret the aml eln 2022 result against the thresholds and context described above.

How to Use

Enter the cytogenetics, molecular mutations for the scenario you are assessing. Classify AML risk per European Leukemia Net 2022 criteria into favorable, intermediate, or adverse categories based on cytogenetics and molecular mutations to guide induction and consolidation decisions. Use the aml eln 2022 result to inform your calculation.

Related Calculators

AML Blast Threshold

Medical Long-tail

FLT3-ITD Ratio

Medical Long-tail

Frequently Asked Questions